| scholarly article | Q13442814 |
| P2093 | author name string | Yoshihiro Kuroda | |
| Minoru Nakano | |||
| Tetsurou Handa | |||
| Munetaka Hirose | |||
| Yoshihiko Watanabe | |||
| Mineo Abe | |||
| P2860 | cites work | Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family | Q24314750 |
| Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors | Q24339400 | ||
| The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease | Q24677033 | ||
| Crystal structure of the tyrosine kinase domain of the human insulin receptor | Q27730800 | ||
| Cell signaling by receptor tyrosine kinases | Q27860474 | ||
| Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates | Q28624927 | ||
| All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor | Q28626012 | ||
| Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog | Q29616450 | ||
| Physiological concentrations of purines and pyrimidines | Q29616721 | ||
| Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 | Q29617290 | ||
| Mechanism of biological synergy between cellular Src and epidermal growth factor receptor | Q30454480 | ||
| Two EGF molecules contribute additively to stabilization of the EGFR dimer | Q33885990 | ||
| 1H-NMR and circular dichroism spectroscopic studies on changes in secondary structures of the sodium channel inactivation gate peptides as caused by the pentapeptide KIFMK. | Q34171258 | ||
| Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
| Autophosphorylation sites on the epidermal growth factor receptor. | Q34245370 | ||
| Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins | Q34334946 | ||
| Protein kinase inhibitors as a therapeutic modality | Q35155768 | ||
| Mechanism of suppression of insulin signalling with lignocaine | Q35569006 | ||
| Intrasteric regulation of protein kinases and phosphatases | Q36418496 | ||
| Block of brain sodium channels by peptide mimetics of the isoleucine, phenylalanine, and methionine (IFM) motif from the inactivation gate | Q36421269 | ||
| The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors | Q38298693 | ||
| Tyrosine kinase inhibition: an approach to drug development | Q40613606 | ||
| Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling? | Q41194565 | ||
| Restoration of inactivation and block of open sodium channels by an inactivation gate peptide | Q41469205 | ||
| Autoregulatory mechanisms in protein-tyrosine kinases | Q41758716 | ||
| Identification of a novel autophosphorylation site (P4) on the epidermal growth factor receptor | Q41928036 | ||
| Suppression of insulin signalling by a synthetic peptide KIFMK suggests the cytoplasmic linker between DIII-S6 and DIV-S1 as a local anaesthetic binding site on the sodium channel | Q42000720 | ||
| Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor. Formation of both phosphoserine and phosphotyrosine | Q42448440 | ||
| Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides | Q42820490 | ||
| Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 | ||
| A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus | Q63343005 | ||
| Nonphosphorylatable substrate analogs selectively block autophosphorylation and activation of the insulin receptor, epidermal growth factor receptor, and pp60v-src kinases | Q69199976 | ||
| Epidermal growth factor receptor tyrosine kinase inhibitors | Q80103312 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 402-411 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Inhibition of autophosphorylation of epidermal growth factor receptor by small peptides in vitro | |
| P478 | volume | 147 |
| Q34692050 | A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro |
| Q36790294 | Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression |
| Q27323236 | Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation |
| Q92730713 | EGFR-c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells |
| Q35786713 | Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma |
| Q45794953 | Naturally occurring phenolic acids modulate TPA-induced activation of EGFR, AP-1, and STATs in mouse epidermis. |
| Q50765370 | Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo. |
| Q38842692 | Src and epidermal growth factor receptor mediate the pro-invasive activity of Bcl-w |
| Q38971568 | The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells |
Search more.